Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Confer

Related Keywords

Belgium ,United States ,Mont Saint Guibert ,Waals Gewest ,Olivier Taelman ,David Demartino ,Healthcare Medtech Services Conference ,Nasdaq ,Company Investor Relations ,Annual Healthcare Medtech ,Obstructive Sleep Apnea ,Services Conference ,Chief Executive Officer ,Investor Relations ,Investor Presentation ,Shareholder Information ,Euronext Brussels ,Complete Concentric Collapse ,Chief Strategy ,